AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

El.En.

Investor Presentation Nov 18, 2025

4393_rns_2025-11-18_0ba7bdef-d190-46b3-ac94-90cc7bdf4d28.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

COMPANY PRESENTATION

IntermonteEuropean MidCap Conference

Virtual

November 19th, 2025

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, noforward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes noobligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.

  • 1. Overview
  • 2. Markets and Growth Drivers
  • 3. Our Strategy and Market Approach
  • 4. Financial Highlights
  • 5. Current Outlook
  • 6. Multiples & Comparables

A PRIMARY PLAYER PROVIDING MEDICAL,INDUSTRIAL AND CONSERVATION LASER SOLUTIONS WORLDWIDE

World Class Hi-Tech company

Hi-Tech industrial group providing laser solutions with proprietary technologies and know how developed over 40 years

Listed on Euronext STAR Milan of Italian Stock Exchange since year 2000 and member of Euronext Tech Leaders

Within Worldwide leaders in its space

Active worldwide on several laser application segments andmarkets…

…progressively widening its globalwide presence achieving continuous growth over the years

OUR APPROACH

40

YEARS OF EXPERIENCE

25

SUBSIDIARIES

9

COUNTRIES WITH DIRECT PRESENCE

9

PLANTS

WE CREATE LIGHT, ENERGY, WAVES

MEDICAL

Our energy based systems improve people's well-being and life quality.

In the SURGICAL SECTOR, our minimally invasive technology systems minimize pain, side effects and risks of surgical procedures and hospitalization days.

In the AESTHETIC SECTOR, our systems satisfy the growing desire of individuals to improve their appearance also reducing pathological or painful imperfections.

INDUSTRIAL

Our LASER CUTTING and MARKING SYSTEMS Improve the productivity of our customers manufacturing plants also limiting the environmental impact of manufacturing processes minimizing waste, fumes generated by the process, use of chemical additives, and allowing to eliminate the need for inks, solvents or glues within the process.

CONSERVATION

Our LASER SYSTEMS PRESERVE artworks of the universal heritage of our communities.

EthiFinance

ESG ratings

OUR APPROACH

MSCI ESG RATINGS

Sustainalytics

OUR STRATEGY FOR A SUSTAINABLE FUTURE:

Create value over time and be ready to successfully meet the future challenges

R&D

5 R&D dept

15 MLN
Yearly R&D investments

30 Patents

120 R&D specialists

PRODUCTS

60.000

Laser sources installed worldwide

ISO 9001 e ISO 13485

Certifications

ISO 14064

El.En., Deka Mela and Quanta

50 Quality & Regulatory specialists

PEOPLE

~18% under 30 years

>1.400 employees

33% of employees have a university degree and over 90% hold either a degree or a high school diploma.

WELFARE at the heart of business projects.

Workspaces were renewed for several Group companies: employees well-being was increased and plants'energy efficiency as well

24.000 HOURS

Training

ENVIRONMENT

7 Photovoltaic systems active in 2024

2 Photovoltaic plants in progress

16%

Self-produced electrical energy share of the annual total consumption

39%

Annual electricity consumption comes from renewable sources

All data refers to the Group without Chinese divi

Pigmented lesions

Antiaging/Pigmented lesions

Compact sheet metal cutting system

MINIMALLY INVASIVE SURGERIES:

  • •Lower risks and side effects
  • •Faster recovery /Shorter hospital stays
  • •Savings by Private & National Health Systems
  • •Attractive ROI for surgical services providers
  • •Rapidly Growing Urology laser market
  • •Consumables revenue stream in Urology

MEDICAL AESTHETICS MARKET TRENDS

  • • Aging demographics and increasing focus on improving appearance and youthfulness
  • • Cosmetic procedures as preventive measures for and to slow down the aging process
  • • Growing interest in non-invasive or minimally invasive procedures and awareness of energybased aesthetic treatments
  • • Reduction in procedure costs, attracting a broader patient base
  • • Aesthetic procedures becoming part of lifestyle and increasingly part of people's wellbeing
  • •Rapid growth expected

MARKET RESEARCHES GROWTH ESTIMATES

GLOBAL MEDICAL LASER MARKET

Mordor Intelligence CAGR 13,4% to 2028
Fortune business insights CAGR 13,1% to 2030
Global Market Insights CAGR 14,5% to 2032
Research and Markets CAGR 13,2% to 2030

With an estimated market size of $\approx$ \$5 Bln in 2021 including:

  • Ophthalmology Dermatology Aesthetics- Dentistry
  • Surgical -Gynecology Urology Cardiovascular

AESTHETIC LASER AND ENERGY DEVICES MARKET

Research and Markets
CAGR 9,45% 2023- 2028
\$ 3,7Bn 2023 Market Size

Tecnavio CAGR 10,9% 2023- 2028

\$3,9Bn 2023 Market Size

Laser cutting applications:

  • • Laser power increase + Cost reduction: enhanced flexibility, productivity and quality standards in manufacturing processes.
  • •Automation for increased productivity
  • •New application verticals
  • •Building and construction

Laser marking:

  • •Products identification and traceability
  • •Minimal environmental impact

Laser processing market:

•Size: \$17,48 billion in 2021

•Expected CAGR to 2030: 9,1%

Source: Grand view research

Technical Knowledge

Electronics

Optics

Photonics

Mechanics

Fluid dynamics

Power electronics

Software

LASER

Application Expertise

Aesthetics

Surgery

Dermatology

Physiotherapy

Art Conservation

  • •Flexibility
  • •Speed
  • •Power
  • •Precision
  • •Selectivity
  • •Effectiveness

MID-TERM STRATEGIC VISION BASED ON:

  • • Continuous investment in R&D: maintaining the unmatched wideness of our product range by innovating existing technologies and developing new ones
  • •Cooperation with primary research institutions and KOL'S
  • • Excellent coverage of the target markets based on the widespread and loyal distribution network created over the years
  • • Focus on innovative products release, technical support and continuous training to our customers
  • Unique Multi brand approach

Physiotherapy

WIDE RANGE OF PRODUCTS IN MEDICAL SECTOR20

Hair removal Tattoo removal & Pigmented lesions

Body Contouring

Skin Rejuvenation

Surgery

Dermatology

Art Conservation

Innovative

  • gentle and

painful

User friendly

LINEAR CUBE

Teleborsa:
distribution
and
and commercial
use
strictly
prohibite
Euro '000 30/09/2024 % 30/09/2025 % Var. %
unaudited unaudited
Medical 294.013 72,4% 307.537 72,9% 4,6%
Industrial 112.219 27,6% 114.394 27,1% 1,9%
Revenues 406.232 100,0% 421.931 100,0% 3,9%
Gross margin 176.928 43,6% 188.342 44,6% 6,5%
Operating Expenses 39.445 9,7% 44.550 10,6% 12,9%
Staff espenses 71.561 17,6% 78.155 18,5% 9,2%
EBITDA 65.922 16,2% 65.637 15,6% -0,4%
Depr., amort., accruals 9.025 2,2% 10.602 2,5% 17,5%
EBIT 56.896 14,0% 55.035 13,0% -3,3%
Net financ.income(charges) (693) -0,2% (1.778) -0,4% 156,5%
Other income (expense) net 5.024 1,2% (1.078) -0,3%
EBT 61.228 15,1% 52.180 12,4% -14,8%
31/12/24 30/09/25
unaudited
Net financial position 110.559 137.399

Euro '000 2024-Q3 % 2025-Q3 % Var. %
unaudited unaudited
Revenues 134.761 100,0% 136.595 100,0% 1,4%
Gross margin 57.097 42,4% 62.131 45,5% 8,8%
Operating Expenses 11.327 8,4% 13.607 10,0% 20,1%
Staff espenses 23.227 17,2% 25.110 18,4% 8,1%
EBITDA 22.543 16,7% 23.414 17,1% 3,9%
Depr., amort., accruals 2.910 2,2% 3.027 2,2% 4,0%
EBIT 19.632 14,6% 20.387 14,9% 3,8%
Net financ.income(charges) (723) -0,5% 884 0,6%
Other income (expense) net 24 0,0% (817) -0,6%
EBT 18.933 14,0% 20.454 15,0% 8,0%
_ -

certified

<-- PDF CHUNK SEPARATOR -->

* Nopat =Ebit-Income tax

**D&A= Depreciation, Accruals and Devaluation

***NWC= Net Working Capital

Industrial: +2%

in Euro million

Medical: +5%

in Euro million

Revenues 2025 &gt; Revenues 2024

EBIT 2025 &gt; EBIT 2024

Stockholder's Equity per share 5,2
Price / Book Value Adj. 2,1
EV /EBIT (95% EBIT) 10,7
EV / Sales (95% Sales) 1,4
El.En. Market Cap. 890,6 @ €11,10
Net financial position 137,4 @ 30/09/2025
Financial investments m/l term 10,7 @ 30/09/2025
Enterprise Value 742,5

emanket sdir storage certified

MULTIPLES

TM.
ELEN
Se
t
p
h,
3
0
t
2
0
2
5
-------------- ------------------- ------------------
\$
1
4,
6
1
\$
2
6
7
(
*)
(
*)
lu
Va
e
-1
0
%
\$
5
9
2
2
%
\$
9
2
3
\$
3
9
6
1,
1
5,
0
1,
4
\$
1,
3
3
\$
2
1
8
%
-1
3
\$
(
)
2
1
%
-1
0
\$
1
7
0
\$
3
2
9
1,
1
n.
a.
2,
6
\$
8
1,
7
\$
3
4
2
%
-1
\$
(
)
2
8
-6
%
5
\$
3
\$
5
0,
1
n.
a.
3
1,
\$
0,
9
5
\$
1
6
5
-2
%
\$
1
3
8
%
\$
2
8
7
\$
2
6
2
0,
8
9,
9
0,
6
\$
7
6
3,
5
5
\$
5
9
4
2
%
\$
3
5
%
\$
2
7
1
\$
2
4
5
3,
1
6
8,
0
9,
7
\$
4,
6
6
\$
7
0
3
1
%
\$
2
5
3
6
%
\$
4
1
9
\$
3
6
9
4,
0
1
1,
1
4,
4

3
3,
6
1

1
5
4
3
5
%

7
6
4
9
%

2.
1
9
9

2.
1
4
6
1
0,
5
2
1,
3
7,
0
du
In
ia
l
tr
s
\$
8
5,
1
6
\$
7
2
9
-2
%
\$
1
0
1
%
\$
3.
5
9
0
\$
2.
7
5
2
2,
8
2
1
1,
5
1,
7
¥
3
9,
4
4
¥
1
2.
7
1
3
2
7
%
¥
5
5
7
4
%
¥
4
0.
2
0
0
¥
4
2.
1
5
3
2,
5
5
6,
9
2,
4
C
H
F
2
4
4
C
H
F
3
0
5
-8
%
-C
H
F
8
-3
%
C
H
F
4
5
1
C
H
F
6
8
0,
1
n.
a.
0,
7
1.
8
2
6
J
P
Y
3
0
6.
1
1
9
J
P
Y
%
1
3
4.
5
9
7
J
P
Y
%
1
1
5
9
9.
2
4
0
J
P
Y
5
3
0.
4
8
6
J
P
Y
1,
3
1
1,
5
1,
1
3
2
1
J
P
Y
2.
0
0
7
J
P
Y
0
%
-1
-9
0
J
P
Y
%
-4
3
0
1.
4
J
P
Y
2.
8
5
1
J
P
Y
0,
9
n.
a.
2
1,
3,
3
¥
7
4
0
3
8
¥
1
1.
2
3
%
0
6
¥
1.
5
0
%
1
2.
8
0
¥
7
4
0
8
6
¥
7
5.
5,
1
3,
0
5
6,
6

1
1,
1
0

4
2
2
4
%

5
5
1
3
%

8
9
1

7
4
3
1,
4
1
0,
7
2,
1

(1) EV and multiplies as for previous slide

(2) Financials @ 30.06.25

(*) Revenue,Ebit and earnings annualized

CONTACTS

El.En. S.P.A.

Enrico RomagnoliInvestor Relations Managertel. +39 055-8826807

E-mail: [email protected]

POLYTEMS HIR

Financial Communication, IR and Press OfficeBianca Fersini Mastelloni - [email protected] Silvia Marongiu - [email protected] Tel. +39 06-69923324

Talk to a Data Expert

Have a question? We'll get back to you promptly.